Tuesday, September 30, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

ECOG-ACRIN research at ASCO 2024

April 24, 2024
in Cancer
Reading Time: 3 mins read
0
ECOG-ACRIN research at ASCO 2024
66
SHARES
596
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a range of research findings at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31 to June 4, 2024. The National Cancer Institute, part of the National Institutes of Health, funded these studies.

Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a range of research findings at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31 to June 4, 2024. The National Cancer Institute, part of the National Institutes of Health, funded these studies.

Abstract titles are now available. Below are five highlights among the 14 abstracts to be presented by researchers affiliated with ECOG-ACRIN.

 

Prostate Cancer – Late-breaking abstract submission

  • Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: the CHAARTED2 Trial (EA8153). Abstract LBA5000. Background here.

 

Breast Cancer – A prospective trial that enrolled only Black women

  • ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Variants and Taxane Type in Association with Taxane-Induced Peripheral Neuropathy (TIPN) in Black Women with Early-Stage Breast Cancer. Abstract 503. Background here.

 

Pancreas Cancer – First randomized, prospective national trial of its kind; represents a new approach to geriatric assessment, which can be used in other trials

  • A Randomized Phase 2 Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naive Metastatic Pancreatic Cancer (GIANT): ECOG-ACRIN EA2186. Abstract 4003. Background here.

 

Head and Neck Cancer – Follow-up on a practice-changing approach using less radiation

  • Long-Term Follow-Up of E3311, A Phase 2 Trial of Transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer. Abstract 6009. Primary publication: Ferris RL. J Clin Oncol. 2021.

 

Prostate Cancer – Evaluation of the use of AI for prognosis

  • Prognostic Validation of a Digital Pathology-Based Multi-Modal Artificial Intelligence (MMAI) Biomarker in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) from the CHAARTED Trial. Abstract 5077.

 

Interviews

ASCO will release the majority of abstracts on Thursday, May 23, at 5:00 PM (ET). Abstracts are under the ASCO news embargo until then. Please follow the ASCO 2024 Annual Meeting Media Policies. To request an interview under embargo with the authors of any of the abstracts above, email Diane Dragaud, Director of Communications, or call 215-789-3631.

About ECOG-ACRIN

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is an expansive membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer. The Group comprises nearly 1400 member institutions and 21,000 research professionals in the United States and around the world. ECOG-ACRIN is known for advancing precision medicine and biomarker research through its leadership of major national clinical trials integrating cutting-edge genomic approaches. Member researchers and advocates collaborate across more than 40 scientific committees to design studies spanning the cancer care spectrum, from early detection to management of advanced disease. ECOG-ACRIN is funded primarily by the National Cancer Institute, part of the National Institutes of Health. Follow us on Twitter/ X @eaonc, Facebook, LinkedIn, and Instagram, or call 215.789.3631.



Share26Tweet17
Previous Post

Startup financing gender gaps greater in societies where women are more empowered

Next Post

Postpartum depression after adolescent stress shows a dysregulated HPA axis: a cross-species translational study

Related Posts

blank
Cancer

Decade-Long Clinical Trial Reveals Radiation Matches Surgery in Treating Early-Stage Non-Small Cell Lung Cancer

September 30, 2025
blank
Cancer

NRG Oncology Trial Reveals Improved Bowel Health Quality of Life in Localized Immediate Risk Prostate Cancer Patients Treated with Stereotactic Body Radiation Therapy

September 29, 2025
blank
Cancer

Shorter Radiation Enhances Patient Comfort Without Boosting Disease Control in Intermediate-Risk Prostate Cancer

September 29, 2025
blank
Cancer

First Randomized Trial Shows Proton and Photon Radiation Therapies Equally Preserve Quality of Life in Breast Cancer Patients

September 29, 2025
blank
Cancer

Actin Scaffold Within Cell Nucleus Sheds Light on Cancer Cell Survival Mechanisms

September 29, 2025
blank
Cancer

Hypoxia Triggers Reversible Cell Cycle Arrest in Lung Cancer

September 29, 2025
Next Post
Minae Niwa, Ph.D.

Postpartum depression after adolescent stress shows a dysregulated HPA axis: a cross-species translational study

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27560 shares
    Share 11021 Tweet 6888
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    969 shares
    Share 388 Tweet 242
  • Bee body mass, pathogens and local climate influence heat tolerance

    646 shares
    Share 258 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    513 shares
    Share 205 Tweet 128
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    473 shares
    Share 189 Tweet 118
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Tumor Histology: Lineage Plasticity as a Spectrum
  • Party Cues Influence Large Language Model Labeling Decisions
  • Humans, LLMs Prefer Deliberation Over Intuition in Reasoning
  • Efficient Neural Spike Compression for Brain Implants

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,185 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading